My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: alliance management  alliances  collaboration  partnering  alliance  alliance managers  partners  alliance manager  partner  partnerships  ecosystem  The Rhythm of Business  governance  Jan Twombly  partnership  Strategic Alliance Magazine  Eli Lilly and Company  IoT  Vantage Partners  biopharma  Healthcare  NetApp  2015 ASAP Global Alliance Summit  ASAP BioPharma Conference  Cisco  IBM  strategy  Christine Carberry  digital transformation  innovation 

ASAP BioPharma Conference Keynoter Dr. Sam Nussbaum: ’An Industry under Siege Must Take on a Different Social Contract’

Posted By John W. DeWitt, Wednesday, October 5, 2016

A couple of weeks ago, renowned physician Dr. Samuel Nussbaum—who served as chief medical officer for Anthem through 16 years of dramatic change in the healthcare industry—took the stage at the Sept. 7-9, 2016 ASAP BioPharma Conference in Boston with a big grin, twinkling eyes, and an embrace of new ASAP Chairman Brooke Paige. Paige introduced Dr. Nussbaum and noted that speaking in Boston was a homecoming for “America’s Physician,” who trained in internal medicine at Massachusetts General and then in endocrinology at Harvard. Indeed, Nussbaum, who is now strategic consultant for EGB Advisors, paid homage to the Boston and Cambridge, Mass., area’s medical science history and still-expanding potential for academic partnerships.

“One only has to go a few blocks west of here to see where Merck began to work with Harvard; Novartis has a research center near MIT in Cambridge,” Nussbaum noted. Then he turned serious. “It’s great to be here,” he began, “but it’s also an extraordinary time in healthcare, an industry, a space, under siege. It’s no longer fully understandable to say we discover, we cure, we make health better for the world. One has to take on a different social contract … and drive collaboration.”

Nussbaum echoed Dickens’ famous description of the Elizabethan era in England.

“We live at a time which is unprecedented. It’s the best of times, because we are in an age of unprecedented advances in medical technology and human science, yet it’s the worst of times, because we have a healthcare system in the US and around the world that doesn’t provide access for everyone. The state of public health is not a focus; the quality of medical care doesn’t keep pace with the science. Looking back to halcyon days, we had a great healthcare system [in the US] and research leading to some of the most extraordinary advances in healthcare. Yet we have storm clouds on the horizon.”

Nussbaum discussed a variety of driving forces vs. restraining forces

  • Breakthrough science vs. affordability for government and private payers
  • Personalized medicine vs. reputation issues
  • Technology, big data, bioinformatics vs. value-based payment models, bundled payment
  • Patient-centered outcomes and clinical design vs. impact of consolidation

He juxtaposed several triumphs of modern medicine with what has become a key factor in recent news coverage of the pharma industry and in the run-up to 2016 US presidential election.

“Cardiac death rates dramatically reduced. Antiviral drugs transform HIV into a chronic illness vs. a killer. And screening and better drugs improve cancer survival. But there is anger, there is outrage,” over high-profile drug price increases in the US and lack of access in other places in the world. “Why are people so angry? Because they can’t afford, and as nations, we can’t afford, the cost of healthcare,” he said. “Over the last decade, the average US family wage hasn’t changed much—from $49,309 to $53,800. Why the movement to Sanders or Trump? Capitalizing on outrage.”

He further explained the context of this outrage—and why expanded coverage (in Massachusetts and across the US under Obama’s Affordable Care Act) hasn’t been the cure-all for healthcare in the US.

“Massachusetts was the first state to have universal coverage. It was done under ‘Romney Care,’ similar to ‘Obamacare,” he said. The problem? “In Massachusetts, healthcare costs went up $5.1 billion and everyone applauded that type of access. But look what happened to other essential services: public health spending down 40 percent; mental health spending down 33 percent, etc.” In other words, Nussbaum explained, “We stole from what are called the social determinants of health. We know that education and housing leads to better health and better health outcomes,” while costing less. In other words, prevention costs much less than the healthcare cure.

“More importantly,” Nussbaum continued, “we are not using our $3.2 billion wisely—30-40 percent of healthcare spending is wasted on unnecessary services, administrative costs, prices, fraud. This is what we have to contend with. That’s why it is about collaboration, why it is the focus of the Obama administration, and of private business, to introduce reforms.”

Don’t miss “Dr. Sam Nussbaum: Healing the US Healthcare System One Politician at a Time,” my colleague Genevieve Fraser’s previous blog coverage of Dr. Nussbaum’s keynote address

Tags:  Anthem  ASAP BioPharma Conference  big data  bioinformatics  Brooke Paige  bundled payment  Dr. Samuel Nussbaum  driving forces vs. restraining forces  EGB Advisors  Harvard  healthcare  Merck  MIT  Novartis  Personalized medicine  reputation issues  Technology  value-based payment models 

Share |
PermalinkComments (0)
 

Summer 2016 Issue of Strategic Alliance Magazine: Partnering for the Fourth Industrial Revolution; SAM Celebrates Five Years of Ink; Behind the BioPharma Conference Podiums

Posted By Cynthia B. Hanson, Thursday, September 1, 2016
Updated: Saturday, August 27, 2016

Happy Birthday, Strategic Alliance Magazine! This summer’s 60-page issue, formerly known as the Q2 edition, celebrates five years of the ups, downs, and inside-outs covering cutting-edge alliance management topics, as documented by John W. DeWitt. Turn the page, and readers can explore alliance management’s critical role in the fourth industrial revolution, as foreseen by forecasters Jan Twombly, CSAP, and Jeff Shuman, CSAP, PhD, principals of The Rhythm of Business, and Lorin Coles, CSAP, co-founder and CEO of Alliancesphere, LLC. The cover story encourages readers to envision their companies orchestrating the speed, complexity, scope, and scale of the emerging ecosystem, and probes what will be required to stay attuned to the rhythm. “One thing is certain,” they predict. “If you do nothing to build understanding and capability to partner with an eco­system perspective, your company will be leaving value on the table at best—and at worst may find it­self left behind.”

 

This issue of SAM is certain to open your thought in other ways with a sneak peak of the new ASAP-commissioned 6th State of Alliances research report, “The Economics of Alliances, Social Capital, and Alliance Performance,” authored by Shawn Wilson, PhD, DBA, vice president and general manager at Beaulieu West Textiles. For the first time ever, ASAP provides hard numbers through economic and financial metrics that can be applied to enhance your company’s partnering and revenue.

 

Also on the “thought provoking” side is an Up Front book review “Committing to Collaborate” by ASAP CEO Michael Leonetti, CSAP, highlighting Martin Echavarria’s book Enabling Collaboration: Achieving Success Through Strategic Alliances and Partnerships. Leonetti wishes he had owned Echavarria’s book years ago because of its wise collaboration advice. An accomplished business coach for companies such as MasterCard, Verizon, Hewlett-Packard, Scotiabank, and American Express, Echavarria’s key argument is that partners should frame opportunity based on mutual understanding and core competencies, foster relationships over time, and make collaboration central with solid relationships when in the process of securing the commitment to development. Negotiating the collaboration portion of the deal will result in more sustainable alliances, he emphasizes over and over again. The review is an introduction to SAM’s engaging new book review feature—with many more insightful reviews to come.

 

If you’re wondering about this year’s 2016 ASAP BioPharma Conference

 “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed” Sept. 7-9, at the Revere Hotel in the heart of Boston, read the preview of the timely keynote address “Healing the U.S. Health Care System: Collaboration is Essential” by Dr. Sam Nussbaum, strategic consultant, EGB Advisors, Inc. Nussbaum will touch on the impact of the presidential elections on healthcare and offer insights from his considerable experience streamlining and orchestrating healthcare between public and private entities. The plenary will be presented the following morning, Sept. 8, by Stéphene Thiroloix, CEO at Mayoly Spindler, who will share his perspective on leadership challenges in biopharmaceuticals and healthcare in “The View from the C-Suite: Partnering and Alliances Today and Tomorrow.”

 

This rich issue also includes a Member Spotlight interviewing Citrix’s Steve Blacklock on how partnering has driven Citrix to the cloud, and we continue our Cultural Roundtables coverage from the March 1-4 2016 Global Alliance Summit, “Partnering Everywhere: Expert Leadership for the Ecosystem,” held at the Gaylord National Resort & Convention Center, National Harbor, Maryland. Part II delves into another aspect of the intensive two-hour session where participants explored cultural aspects of a region in relation to business acumen. The Spring issue covered China; this issue explores forging relationships in India and Latin America.

 

Eli Lilly and Company has provided another topical editorial supplement, “Better Together: Best Alliance Practices for Building a Better Brand,” by

Markus Saba and David S. Thompson, CA-AM. Finally, in The Close, our publisher and editor describes the message that came through “loud and clear” from the last conference he attended—partnering and collaboration truly are everywhere. We look forward to sharing with you this Summer 2016 issue of SAM that is chock full of exceptional collaborations, companies, individuals, and ideas. It’s been a terrific five years of SAM and ASAP Media—and we look forward to many more to come.

Tags:  6th State of Alliances  Alliance Practices  Alliancesphere  Citrix  cultural  David Thompson  Dr. Sam Nussbaum  ecosystem  EGB Advisors  Eli Lilly and Company  Inc.  Jan Twombly  Jeff Shuman  Loren Coles  Markus Saba  Martin E  Mayoly Spindler  Shawn Wilson  Stéphene Thiroloix  Steve Blacklock  The Rhythm of Business 

Share |
PermalinkComments (0)
 

Keynote Speaker “Dr. Sam” To Prescribe More Collaboration as Part of the Cure for US Heathcare Ailments at ASAP’s BioPharma Conference

Posted By Cynthia B. Hanson, Tuesday, August 30, 2016
Updated: Saturday, August 27, 2016

He’s a respected medical officer as well as a major mover and shaker in the area of healthcare reform. To those who know him personally, however, Dr. Sam Nussbaum is the wise and approachable “Dr. Sam.” The distinguished healthcare policy expert will be up on the podium at ASAP’s 2016 BioPharma Conference diagnosing woes and handing out prescriptions in relation to the changing political and healthcare scene in his talk “Healing the U.S. Health Care System: Collaboration is Essential” Wednesday, Sept. 7 at the conference “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed” at the Revere Hotel, Boston Common, Boston.

 

As a strategic consultant at EGB Advisors, Inc., the consulting arm for Epstein, Becker & Green, he advises healthcare, life science companies, physicians, hospitals, and provider organizations. He also served as the former executive vice president, clinical health policy, and chief medical officer at Anthem Health from 2000 to 2016, where he was acted as the key spokesperson and policy advocate and oversaw clinical strategy and corporate medical and pharmacy policy. He was responsible for HealthCore, Anthem's clinical outcomes research subsidiary, and helped create the model for the Food and Drug Administration’s Safety Sentinel System. Recognized by Modern Healthcare as one of the "50 Most Influential Physician Executives in Healthcare," he received the 2004 Physician Executive Award of Excellence from the American College of Physician Executives.

"Sam is the ‘advisor to healthcare advisors,’” says Brooke Paige, staff vice president, strategic initiatives at HealthCore, Inc. “He is sure to bring a dynamic energy and unique perspective to the ASAP Biopharma Conference. Sam is a true clinician, always keeping the patient in mind. As we talk about how our healthcare landscape may change in response to the upcoming presidential election, “Dr. Sam” can advise what potential election outcomes could mean for each segment of the industry."

 

Nussbaum is known for his exceptional role in creating collaborative solutions between Anthem, HealthCore, hospital systems, the FDA, and public agencies. He is well-versed in the value of partnering to solve systemic problems at the highest of levels, having helped design and promote patient-centered medical homes and assessed their impact on the quality and cost effectiveness of care. Under his leadership, HealthCore has built partnerships with federal agencies and academic institutions to advance drug safety, comparative effectiveness, and outcomes research.

“Dr. Nussbaum is uniquely qualified to discuss collaborative approaches and help attendees define ecosystem problems specific to their business while envisioning strategic partnering options to best address an alliance challenge,” says ASAP CEO Mike Leonetti, CSAP, of the choice. “We know as partnership professionals, that the US healthcare system will never be fixed without a collaborative approachit's just too complex not to bring the payors, providers, industry, and government participants together.  In addition, Nussbaum is a policy guru with strong healthcare policy experience and can help attendees prepare for a range of potential scenarios stemming from evolving healthcare policy impacted by the presidential elections.”

 

While serving at chief medical officer at WellPoint, he was accountable for $100 billion in healthcare expendituresfrom clinical pharmacy programs to care and disease management. The HealthCore subsidiary built partnerships during that time to further outcomes research, drug safety, and comparative effectiveness with large federal agencies, such as the Centers for Disease Control and FDA, as well as academic institutions.

 

He received his medical degree from Mount Sinai School of Medicine, and trained in internal medicine at Stanford University Medical Center and Massachusetts General Hospital. He also trained in endocrinology and metabolism at Harvard Medical School and Massachusetts General Hospital. He currently serves on the Board of Directors of the OASIS Institute, NEHI, BioCrossroads (an Indiana-based public-private collaboration that advances and invests in the life sciences), and America's Agenda. He is a member of the Scientific Advisory Board of Medidata, a publicly traded clinical technology company serving life sciences clients, and the Healthcare Advisory Board of KPMG. He serves as Chair of the Centers for Education & Research on Therapeutics (CERTs) Steering Committee (a cooperative agreement between AHRQ and the FDA), is a member the HHS Health Care Payment Learning and Action Network (LAN) Guiding Committee, and participates in Institute of Medicine activities, including serving on the Roundtable on Value & Science-Driven Health Care.

 

For more information about the 2016 ASAP BioPharma Conference and keynote speaker Sam Nussbaum, go to http://www.asapweb.org/biopharma/.

Tags:  Anthem Health  ASAP BioPharma Conference  collaborative solutions  Dr. Sam Nussbaum  EGB Advisors  FDA  healthcare  HealthCore  hospital systems  Inc.  life science companies  partnerships  public agencies  WellPoint 

Share |
PermalinkComments (0)
 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630